
维百奥生物可提供FormuMax品牌产品。
【声明1】我司本网页所展示产品列表、Logo、图片、商标、品牌中英文名字,仅作为客观展示产品所用,如有侵权,请联系随时联系我司。
【声明2】我司不销售归类为危险品或其他违规品的产品,但由于本行业产品货号、型号众多,我司在发布时,难免遗漏,如在网页上显示某一货号或品名属于危险品或其他违规品,不代表我司倾向宣传或有意愿销售该产品;欢迎各界朋友批评指正,我们将立即改正。
【声明3】本网页所展示的品牌和产品,仅用于科学研究,不可用于人体、不可用于诊断或治疗。
FormuMax Scientific是重要的脂质体与纳米药物递送领域专业供应商,公司专注于脂质体与脂质纳米颗粒(LNP)技术,服务于制药、生物技术、化妆品及营养品行业的药物递送与配方开发需求。FormuMax Scientific建立了涵盖载药脂质体、巨噬细胞清除脂质体、预制脂质体、荧光标记脂质体和转染试剂的完整产品线。其旗舰产品Clophosome®(氯磷酸二钠脂质体)单次注射后巨噬细胞清除率可达80-90%,稳定性高且适用于多种给药途径;Doxoves®(盐酸多柔比星脂质体)包埋药物浓度高达4.0 mg/mL,产品特性可媲美商业化Doxil®;Mikosome®系列外泌体模拟脂质体提供荧光素、罗丹明、DiR等多种标记选择。公司还提供高水平的生物化学工程解决方案,专注于高分子量蛋白-脂质体偶联(150-500 kDa三聚体)和先进mRNA/核酸封装。FormuMax Scientific的产品线涵盖预制脂质体试剂、转染试剂、PEG衍生物、聚碳酸酯薄膜及脂质体稀释液等辅助产品,广泛应用于基础研究、药物筛选、基因治疗和疫苗开发等领域。

❑ FormuMax产品线
●预制脂质体:提供非PEG化(如DSPC/CHOL,100nm)和PEG化(如HSPC/CHOL/mPEG2000-DSPE,85nm)的通用型空白脂质体,可用于药物包埋的载体筛选。
● 载药脂质体(Doxoves®):提供盐酸多柔比星脂质体(2.0mg/mL和4.0mg/mL)、盐酸拓扑替康和伊立替康脂质体,用于抗肿瘤药物的研发级递送。
● 巨噬细胞清除脂质体(Clophosome®):提供中性或阴离子型的氯二钠脂质体,单次注射可高效耗竭脾脏巨噬细胞(清除率达80-90%),是体内免疫学研究的重要工具。
● 外泌体模拟脂质体(Mikosome®):提供空白及荧光标记(FITC、罗丹明、DiR等)的外泌体模拟脂质体,用于细胞摄取、示踪和药物递送研究。
● 阳离子脂质体:表面带正电荷的脂质体,适用于质粒DNA、反义/干扰RNA等带负电荷核酸分子的细胞转染。
● 荧光标记脂质体:提供常规、生物素化及亲和素化的预制荧光脂质体,并可接受脂质组成和染料类型的客户定制。
● 辅助试剂与转染工具:提供10%蔗糖和1×PBS脂质体稀释液、Trans-Hi™高效细胞转染试剂以及用于脂质体挤出制备的聚碳酸酯薄膜。
❑ FormuMax产品列表
| 品名 | 货号 | 规格 |
| Fluorescein Labelled Mikosome™ (2mL) | FEM072101F | 2.0mL |
| Rhodamine Labelled Mikosome™ (2mL) | FEM072101R | 2.0mL |
| Fluorescent (DiR) Labelled Mikosome™ (2mL) | FEM072101DR | 2.0mL |
| Fluorescent (DiO) Labelled Mikosome™ (2mL) | FEM072101DO | 2.0mL |
| Fluorescent (DiI) Labelled Mikosome™ (2mL) | FEM072101DI | 2.0mL |
| Fluorescent (DiD) Labelled Mikosome™ (2mL) | FEM072101DD | 2.0mL |
| Plain Mikosome™ (Exosome-Mimicking Liposomes, 2mL) | FEM072101 | 2.0mL |
| Lipid Nanoparticles (LNPs) (New) | - | - |
| Control Liposomes for High Potency Clophosome® - A (Anionic) | F70101-AH | 1.0mL |
| Control Liposomes for High Potency Clophosome® (Neutral, 1.0mL) | F70101-NH | 1.0mL |
| High Potency Clophosome® - A (Anionic, 20mg/mL) | F70101C-AH | 1.0mL |
| Clophosome® - High Potency Clodronate Liposomes (Neutral, 20mg/mL) | F70101C-NH | 1.0mL |
| Clophosome®-A, Fluorescent & Plain Control Liposomes | F70101C-AF | 1 vial (2 or 10mL) of DiI fluorescent control liposomes (F70101F-A) |
| Combo: Clophosome®, Fluorescent & Plain Control Liposomes (Neutral) | F70101C-NF | 1 vial (2 or 10mL) of DiI fluorescent control liposomes (F70101N-F) |
| DiI Fluorescent Control Liposomes for Clophosome®-A (Anionic) | F70101F-A | 2.0mL |
| DiI Fluorescent Control Liposomes (Neutral) | F70101F-N | 2.0mL |
| Combo: Clophosome®-A and Control Liposomes (anionic) | F70101C-AC | 2.0mL/10mL |
| Combo: Clophosome® and Control Liposomes | F70101C-NC | 2.0mL/10mL |
| Plain Control Liposomes for Clophosome®-A (Anionic) | F70101-A | 2.0mL/10mL |
| Plain Control Liposomes for Clophosome® (Neutral) | F70101-N | 2.0mL/10mL |
| Clophosome® - Clodronate Liposomes (Neutral) | F70101C-N | 2.0mL/10mL |
| Clophosome®-A - Clodronate Liposomes (Anionic) | F70101C-A | 2.0mL/10mL |
| Liposome Particle Size Standards 100nm | F10103S100 | 2.0mL/10mL |
| Combo kit of Doxoves® (2.0mg/mL) and plain control liposomes | F30204C-D2-2 | 2.0mL/10mL |
| Control liposomes for Doxoves® (2.0mg/mL) | F30204B-C2 | 2.0mL/10mL |
| Doxoves® - STEALTH Liposomal Doxorubicin HCl (2.0mg/mL) | F30204B-D2 | 2.0mL/10mL |
| Liposome diluent: PBS (Phosphate buffer Saline 1X) | FB10030 | 50mL |
| Doxoves® - STEALTH Liposomal Doxorubicin HCl (4.0mg/mL) | F30204B-D | 2.0mL/10mL |
| Liposome diluent- Sucrose solution (10 wt%) | FB10020 | 50mL |
| Dilution Buffer for Doxoves® | FB30020 | |
| Combo kit of Doxoves® and plain control liposomes | F30204C-D-2 | 2.0mL/10mL |
| Control liposomes for Doxoves® (4.0mg/mL, 40mM) | F30204B-C | 2.0mL/10mL |
| Liposomes for Loading Hydrophobic Drugs (5.0mL) | F10209D | 5mL |
| HSPC/CHOL (55:45 mol/mol) Liposomes with Ammonium Sulfate Gradient (100nm) | F20104A | 10mL |
| SUV HSPC/CHOL/mPEG2000-DSPE (56.2/38.5/5.3) Liposomes with Ammonium Sulfate Gradient (85 nm) | F20204AS | 10mL |
| DSPC/CHOL (55:45 mol/mol) Liposomes with Ammonium Sulfate Gradient (100nm) | F20103A | 10mL |
| HSPC/CHOL/mPEG2000-DSPE (56.2:38.5:5.3) Liposomes with Ammonium Sulfate Gradient (100nm) | F20204AB | 10mL |
| HSPC/CHOL/mPEG2000-DSPE (50:45:5 mol/mol) Liposomes with Ammonium Sulfate Gradient (100nm) | F20204A | 10mL |
| DSPC/CHOL/mPEG-DSPE (50:45:5 mol/mol) Liposomes with Ammonium Sulfate Gradient (100nm) | F20203A | 10mL |
| Cationic DOTAP/DC-CHOL Liposome Adjuvants | F50101V | 2.0mL |
| Cationic Liposomes DMTAP/DOPE | F50101 | |
| Cationic Liposomes DC-CHOL/DOPE | F50105 | 2.0mL |
| Cationic Liposomes DODAP/DOPE | F50104 | |
| Cationic Liposomes DOTAP/DOPE | F50102 | 2.0mL |
| Cationic Liposomes DDAB/DOPE | F50103 | 2.0mL |
| Trans-Hi™ - Transfection Reagent Evaluation Sample | F90101TH-00 | |
| Trans-Hi™ - In vitro Transfection Reagent | F90101TH-10 | 0.5, 1.0 and 10x1.0 mL |
| Placebo Control DOPC/CHOL Liposomes (F60103-P) | F60103-P | 1.0mL |
| 200nm DOPC/CHOL Liposomes labeled with Fluorescein DHPE (F60103F2-F) | F60103F2-F | 1.0mL |
| 200nm DOPC/CHOL Liposomes labeled with Texas Red DHPE (F60103F2-TR) | F60103F2-TR | 1.0mL |
| 300nm Non-Fluorescent DOPC/CHOL Liposomes (F60103F3-P) | F60103F3-P | 1.0mL |
| 300nm DOPC/CHOL Liposomes labeled with Rhodamine DHPE (F60103F3-R) | F60103F3-R | 1.0mL |
| 300nm DOPC/CHOL Liposomes labeled with Texas Red DHPE (F60103F3-TR) | F60103F3-TR | 1.0mL |
| 200nm Non-Fluorescent DOPC/CHOL Liposomes (F60103F2-P) | F60103F2-P | 1.0mL |
| 200nm DOPC/CHOL Liposomes labeled with Rhodamine DHPE (F60103F2-R) | F60103F2-R | 1.0mL |
| 300nm DOPC/CHOL Liposomes labeled with Fluorescein DHPE (F60103F3-F) | F60103F3-F | 1.0mL |
| PEGylated DOPC/CHOL Liposomes labeled with DiO | F60203F-DO | 1.0mL |
| PEGylated DOPC/CHOL Liposomes labeled with DiR | F60203F-DR | 1.0mL |
| PEGylated DOPC/CHOL Liposomes labeled with DiI | F60203F-DI | 1.0mL |
| PEGylated DOPC/CHOL Liposomes labeled with DiA | F60203F-DA | 1.0mL |
| PEGylated DOPC/CHOL/mPEG-PE Liposomes labeled with DiD | F60203F-DD | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with DiD | F60103F-DD | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with DiR | F60103F-DR | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with DiO | F60103F-DO | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with DiA | F60103F-DA | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with DiI | F60103F-DI | 1.0mL |
| Placebo Control DOPC/CHOL/PEG2000-DSPE Liposomes (F60203-P) | F60203-P | 1.0mL |
| 100nm, DOPC/CHOL Liposomes Labeled with NBD-PE (F60103F-NBD) | F60103F-NBD | 1.0mL |
| DOPC/CHOL/mPEG-DSPE Liposomes Labeled with NBD-PE (F60203F-NBD) | F60203F-NBD | 1.0mL |
| DOPC/CHOL/mPEG-DSPE Liposomes Labeled with Dansyl DOPE (F60203F-D) | F60203F-D | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with dansyl DOPE (F60103F-D) | F60103F-D | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with Marina Blue-DHPE (F60103F-MB) | F60103F-MB | 1.0mL |
| DOPC/CHOL/mPEG-DSPE Liposomes labeled with Marina Blue-DHPE (F60203F-MB) | F60203F-MB | 1.0mL |
| DOPC/CHOL/mPEG-DSPE Liposomes labeled with TRITC-DHPE (F60203F-TC) | F60203F-TC | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with TRITC-DHPE (F60103F-TC) | F60103F-TC | 1.0mL |
| DOPC/CHOL/mPEG-DSPE Liposomes labeled with Fluorescein DHPE (F60203F-F) | F60203F-F | 1.0mL |
| DOPC/CHOL/mPEG-DSPE Liposomes labeled with Oregon Green 488 DHPE (F60203F-OG) | F60203F-OG | 1.0mL |
| DOPC/CHOL/mPEG-DSPE Liposomes labeled with Texas Red DHPE (F60203F-TR) | F60203F-TR | 1.0mL |
| DOPC/CHOL/mPEG2000-DSPE Liposomes labeled with Rhodamine DHPE (F60203F-R) | F60203F-R | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with Texas Red DHPE (F60103F-TR) | F60103F-TR | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with Oregon Green 488 DHPE (F60103F-OG) | F60103F-OG | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with Fluorescein DHPE | F60103F-F | 1.0mL |
| 100nm DOPC/CHOL Liposomes labeled with Rhodamine DHPE (F60103F-R) | F60103F-R | 1.0mL |
| Liposomes for Loading Hydrophobic Drugs (5.0mL) | F10209D | 5mL |
| Liposome diluent: PBS (Phosphate buffer Saline 1X) | FB10030,Yes | 50mL |
| Liposome diluent- Sucrose solution (10 wt%) | FB10020,Yes | 50mL |
| Plain Pure POPC Liposomes (100 nm) | F10110 | 10mL |
| Plain Pure DOPC Liposomes (100 nm) | F10109 | 10mL |
| Plain HSPC/CHOL Liposomes (55:45 mol/mol, 100 nm) | F10104 | 10mL |
| Plain DSPC/CHOL Liposomes (55:45 mol/mol, 100 nm) | F10103 | 10mL |
| Plain DPPC/CHOL Liposomes (55:45 mol/mol, 100 nm) | F10102 | 10mL |
| Plain HSPC/CHOL/mPEG2000-DSPE Liposomes (50:45:5 mol/mol, 100 nm) | F10204 | 10mL |
| F10203, Plain DSPC/CHOL/mPEG2000-DSPE Liposomes (50:45:5 mol/mol, 100 nm) | F10203 | 10mL |
| Plain DPPC/CHOL/mPEG2000-DSPE Liposomes (50:45:5 mol/mol, 100 nm) | F10202 | 10mL |
| Irinosome STEALTH Liposomal Irinotecan HCl (2.0mg/mL, SOSA-Am) | F30204SA-IT | 2.0mL/10mL |
| Doxoves® - STEALTH Liposomal Doxorubicin HCl (2.0mg/mL) | F30204B-D2 | 2.0mL/10mL |
| Liposome diluent: PBS (Phosphate buffer Saline 1X) | FB10030 | 50mL |
| STEALTH Liposomal Topotecan HCl (2.0mg/mL) | F30204-TT | 2.0mL |
| STEALTH Liposomal Irinotecan HCl (2.0mg/mL) | F30204-IT | 2.0mL |
| Doxoves® - STEALTH Liposomal Doxorubicin HCl (4.0mg/mL) | F30204B-D | 2.0mL |
| Liposome diluent- Sucrose solution (10 wt%) | FB10020 | 50mL |